• Kara C Schvartz-Leyzac, Deborah J Colesa, Christopher J Buswinka, Donald L Swiderski, Yehoash Raphael, and Bryan E Pfingst.
• Kresge Hearing Research Institute, Department of Otolaryngology-Head and Neck Surgery, University of Michigan, 1150 West Medical Center Drive, Ann Arbor, MI, 48109-5616, USA; Hearing Rehabilitation Center, Department of Otolaryngology-Head and Neck Surgery, University of Michigan, 475 W. Market Place, Building 1, Suite A, Ann Arbor, MI, 48108. Electronic address: kleyzac@med.umich.edu.
• Hear. Res. 2019 Nov 1; 383: 107809.

AbstractThe electrically-evoked compound action potential (ECAP) is correlated with spiral ganglion neuron (SGN) density in cochlear implanted animals. In a previous study, we showed that ECAP amplitude growth function (AGF) linear slopes for stimuli with a constant interphase gap (IPG) changed significantly over time following implantation. Related studies have also shown that 1) IPG sensitivity for ECAP measures ("IPG Effect") is related to SGN density in animals and 2) the ECAP IPG Effect is related to speech recognition performance in humans with cochlear implants. The current study examined how the ECAP IPG Effect changed following cochlear implantation in four non-deafened guinea pigs with residual inner hair cells (IHCs) and 5 deafened, neurotrophin-treated guinea pigs. Simple impedances were measured on the same days as the ECAP measures. Generally, non-deafened implanted animals with higher SGN survival demonstrated higher ECAP AGF linear slope and peak amplitude values than the deafened, implanted guinea pigs. The ECAP IPG Effect for the AGF slopes and peak amplitudes was also larger in the hearing animals. The N1 latencies for a constant IPG were not different between groups, but the N1 latency IPG Effect was smaller in the non-deafened, implanted animals. Similar to previously reported results, ECAP measures using a fixed or changing IPG required as many as three months after implantation before a stable point could be calculated, but this was dependent on the animal and condition. For all ECAP measures most animals showed greater variance in the first 30 days post-implantation. Post-implantation changes in ECAPs and impedances were not correlated with one another. Results from this study are helpful for estimating the mechanisms underlying ECAP characteristics and have implications for clinical application of the ECAP measures in long-term human cochlear implant recipients. Specifically, these measures could help to monitor neural health over a period of time, or during a time of stability these measures could be used to help select electrode sites for activation in clinical programming.Copyright © 2019 Elsevier B.V. All rights reserved.

24 keywords...

hide…